News
Genmab A/S acquires Aglaia portfolio company Merus N.V. in US $ 8 billion all cash transaction
December 12, 2025
News Release
Genmab to Acquire Merus, Expanding Late-Stage Pipeline in an all-cash transaction representing a transaction value of approximately USD 8.0 billion.
Read more
MIMETAS Contributes with Human Organ-on-Chip Data to IND Application by argenx
July 11, 2024
The preclinical collaboration focused on investigating the effects of a novel candidate in a human in vitro disease assay in MI...
Read more
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development
November 29, 2023
Strategic joint marketing agreement MIMETAS and Yamaha Motor.
Read more
Sapreme Appoints Experienced Industry Executives, Dr. Jeanne Bolger and Dr. Andre Hoekema, to its Board of Directors
July 20, 2023
Jeanne Bolger and Andre Hoekema Sapreme Board of Directors
Read more
